Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

Nature Immunology

Volumn 3, Issue 3, 2002, Pages 265-271

  Norbury, Christopher C ^a,b   Malide, Daniela ^a   Gibbs, James S ^a   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DESIGN; IN VIVO STUDY; INOCULATION; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; LYMPH NODES; MICE; MICE, INBRED C57BL; VACCINIA VIRUS;

EID: 0036200852     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni762     Document Type: Article

References (40)

1. Mechanisms of MHC class I-restricted antigen processing
2. Degradation of cell proteins and the generation of MHC class I-presented peptides
3. + T cell responses to infectious agents, tumors, transplants, and vaccines
4. In vivo activation of antigen-specific CD4 T cells
5. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens
6. + T cells
7. + T cells in vivo
8. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
9. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice
10. Enumeration of antigen-presenting cells in mice infected with Sendai virus
11. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis
12. The distinctive features of influenza virus infection of dendritic cells
13. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production
14. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
15. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex
16. Inhibition of dendritic cell maturation by herpes simplex virus
17. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
18. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen
19. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response
20. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
21. Recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells
22. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
23. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
24. Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells
25. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 β-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever
26. Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore
27. + T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells
28. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
29. Viral subversion of the immune system
30. Mechanisms of viral interference with MHC class 1 antigen processing and presentation
31. Cellular immune responses to HIV
32. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
33. Tolerance, danger, and the extended family
34. Innate immunity: Impact on the adaptive immune response
35. + T cells
36. T cell receptor antagonist peptides induce positive selection
37. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice
38. Intracellular localization of proteasomal degradation of a viral antigen
39. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
40. Class 1 MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages